# EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients

> **NCT07096258** · — · RECRUITING · sponsor: **Hedera Dx SA** · enrollment: 1000 (estimated)

## Conditions studied

- NSCLC (Advanced Non-small Cell Lung Cancer)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07096258
- **Lead sponsor:** Hedera Dx SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2027-12
- **Final completion:** 2031-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07096258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07096258, "EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT07096258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*